https://www.selleckchem.com/pr....oducts/tofa-rmi14514
ing the early epidemic, the implementation of clinical diagnosis is necessary and effective. A number of studies have looked at dual triggers with hCG and GnRH agonist (GnRHa) in varying doses, but the question remains what is the optimal dose of hCG to minimize ovarian hyperstimulation syndrome (OHSS) and still offer adequate pregnancy rates? The purpose of this study was to compare pregnancy and OHSS rates following dual trigger for oocyte maturation with GnRHa and a low-dose hCG versus hCG alone. A secondary objective was the a
Like
Comment
Share
